Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by toolmantayloron Nov 22, 2016 3:15am
361 Views
Post# 25493725

No, ACB has not peaked.

No, ACB has not peaked. Worth checking some analyst reports by Canaccord and Morningstar. Analysts have released a few reports determining this stock is worth. It is somewhat roughly worth $2.75 CDN Fair Value. Around $1.75 is for the company itself as mediclal currently, and $1 is for the speculative aspect of legalization.

What is interesting is that their value for recreational ($1) is based off of a unrealistically small recreational market of a few billion, and not the 22 billion, never mind 5 billion. Medical can increase as well.

 Additional positive news from the government would push this ($1) number higher. The more people belive a favourable legalization will occur, the more this ($1) is pushed up, explaining why this stock easily hits $3.00 or more sometimes. Nobody will be surprised when these stocks are worth several times what the are now, so do not worry. Many political and company related catalysts can emerge in the meantime.

The analyst releases do not factor in the proposed expansion passing rezoning, or even being approved by town council due in a couple days! This company will be several times bigger in a physical, and fiscal way. Larger facilities mean efficiencies of scale making the product cheaper to produce. Not to mention a variety of 75 strains for sale at one time, when the building is large enough!

It will take a while to realize that with physical expansion of 10 times over, that Aurora shares could go up at least 10 times in value.

Anybody buying in as construction gets a move-on, will be laughing at the end of the build.

Bullboard Posts